YONGTAI

0.255

(%)

OTHERS YONG TAI BERHAD (YTB OR COMPANY) i. HEADS OF AGREEMENT BETWEEN YTB AND SHENZEN KANGTAI BIOLOGICAL PRODUCTS CO. LTD (SZKT) IN RELATION TO THE DEVELOPMENT AND EXCLUSIVE COMMERCIALISATION OF COVID-19 INACTIVATED VACCINE IN MALAYIA (PROPOSED COLLABORATION) ii. ADVISORY AND SERVICE AGREEMENT BETWEEN YTB AND KLINSEL SDN BHD (KSB)

YONG TAI BERHAD

Type Announcement
Subject OTHERS
Description
YONG TAI BERHAD (YTB OR COMPANY) 

i. HEADS OF AGREEMENT BETWEEN YTB AND SHENZEN KANGTAI BIOLOGICAL PRODUCTS CO. LTD (SZKT) IN RELATION TO THE DEVELOPMENT AND EXCLUSIVE COMMERCIALISATION OF COVID-19 INACTIVATED VACCINE IN MALAYIA (PROPOSED COLLABORATION)

ii. ADVISORY AND SERVICE AGREEMENT BETWEEN YTB AND KLINSEL SDN BHD (KSB)

The Board of Directors of YTB (“Board”) wishes to announce that on 4 December 2020, YTB had entered the following documents:

 

(i) Heads of Agreement (“HOA”) with SZKT (collectively referred to as the “Parties” and each as a “Party”) to record the Parties’ agreement for a Proposed Collaboration in relation to the development and exclusive commercialisation (i.e. marketing, distribution and sale) of its Inactivated Covid-19 Vaccine in Malaysia; and

 

(ii) Advisory and Service Agreement (“ASA”) with KSB to appoint KSB as the Contract Research Organisation (“CRO”) for the proposed Phase III Clinical Study of a SZKT Covid-19 vaccine to be conducted in Malaysia.

 

The details of the Announcement in relation to HOA and ASA is attached. 

 

This announcement is dated 4 December 2020.




Please refer attachment below.



Announcement Info

Company Name YONG TAI BERHAD
Stock Name YONGTAI
Date Announced 04 Dec 2020
Category General Announcement for PLC
Reference Number GA1-04122020-00028